RC Capital

RC Capital, established in 1994 and based in Ohio, is a private equity firm specializing in growth-equity investments in healthcare and technology-enabled companies throughout the United States. The firm focuses on partnering with experienced management teams, providing not only capital but also substantial human resources and domain expertise to support its portfolio companies. With over $500 million raised across multiple funds, RC Capital has built a strong reputation for delivering compelling performance and is recognized as a preferred source of growth capital. Currently, the firm is actively seeking new investment opportunities through its latest fund, which has a target of $200 million.

Paul Axelrod

Senior Associate

Patrick Dunnigan

Partner

Daniel T. Fleming

Managing Partner

Britney Hamberg

Director of Operations and Communications

R. Glen Mayfield

Co-Founder

Edward C. McCarthy

Managing Director

Ryan Moeller

Associate

Rurik G. Vandevenne

Managing Partner

Rik Vandevenne

Managing Director

Past deals in Minneapolis

SPR Therapeutics

Series D in 2021
SPR Therapeutics, LLC is a medical device company focused on developing and commercializing interventional pain management therapies. The company specializes in peripheral nerve stimulation (PNS) products, including its flagship Smartpatch system, which provides short-term pain relief following surgeries and for various types of pain such as neuropathic and musculoskeletal pain. Smartpatch is designed for minimally invasive use, allowing for up to 30 days of electrical stimulation to alleviate pain. Additionally, the company offers the Micropulse system for long-term therapy through an implantable PNS solution. SPR Therapeutics aims to provide a non-narcotic alternative to opioids and invasive procedures, emphasizing safety, effectiveness, and affordability in pain management. Founded in 2009 and headquartered in Cleveland, Ohio, the company also has facilities in the Carolinas and Minneapolis.